Trimodality: In addition to Trastuzumab for HER2+ Esophageal Adenocarcinoma: NRG Oncology RTOG 1010 Phase III Trial Lisa Kachnic MD By…
Browsing: ASTRO
iFrame is not supported! MIRAGE Trial Phase 3: CT / MRI SBRT Which is Better? [2022] Which is Better: CT…
MIRAGE Trial Phase 3: CT / MRI SBRT Which is Better? [2022] Which is Better: CT or MRI SBRT in…
7-gene DCIS Assay [2022] Comparing Clinicopathologic Features 7-gene DCIS Assay: For several decades in clinical oncology, when it comes to…
iFrame is not supported! Lung SBRT Dose Optimization [2022]: Overcoming Size & SUV? When Was Lung SBRT (stereotactic body…
7-gene DCIS Assay [2022] Comparing Clinicopathologic Features 7-gene DCIS Assay: For several decades in clinical oncology, when it comes to…
Lung SBRT Dose Optimization [2022]: Overcoming Size & SUV? When Was Lung SBRT (stereotactic body radiation therapy) Treatment Developed?…
iFrame is not supported! NRG / RTOG 1112 Phase 3 Trial: ASTRO [2022] Nrg/RTOG 1112 A Randomized Phase III Study…
iFrame is not supported! Cribriform CAP Intraductal Carcinoma Prostate [2022] Cribriform Prostate Cancer Clinical Trial I’m here to talk…
Does Atezolizumab SBRT Improve Progression-Free Survival In NSCLC? Atezolizumab is an immune checkpoint inhibitor that targets PDL-1. It has been…
Cribriform CAP Intraductal Carcinoma Prostate [2022] Cribriform Prostate Cancer Clinical Trial I’m here to talk about our recent study,…
NRG / RTOG 1112 Phase 3 Trial: ASTRO [2022] Nrg/RTOG 1112 A Randomized Phase III Study The NRG/RTOG 1112 (NRG…